Becton Dickinson & Co
A global medical technology company, BD makes the everyday tools hospitals and labs rely on—syringes, IV catheters, infusion pumps, blood collection tubes, and surgical and diagnostic products sold under brands like BD Alaris and BD Pyxis. It was founded in 1897 when two salesmen, Maxwell Becton and Fairleigh Dickinson, met in a Texas train-station restaurant, discovered they shared the same birthday, and pooled their savings to start a medical supply business in New York City.
Granted 45.3K · Sold 617.7K
Granted 1.11M · Sold 573.6K
Granted 1.28M · Sold 1.16M
Granted 608.5K · Sold 452.3K
Granted 307.2K · Sold 53.0K
Granted 506.2K · Sold 445.8K
Granted 693.3K · Sold 502.9K
Granted 495.3K · Sold 311.8K
Granted 144.0K · Sold 123.0K
Granted 35.6K · Sold 8.1K
Granted 130.4K · Sold 68.8K
Granted 6.2K
Granted 22.5K
Granted 58.1K
Granted 36.0K
Granted 115.0K · Sold 65.0K
Granted 35.8K · Bought 15.0K · Sold 15.0K
Granted 19.4K
Granted 31.9K · Sold 13.0K
Granted 22.4K · Sold 2.2K
Granted 31.9K · Sold 2.6K
Granted 3.4K
Granted 335.5K · Sold 206.8K
Granted 22.3K · Sold 4.4K
Granted 9.4K · Sold 7.9K
Granted 21.8K
Granted 45.1K · Sold 32.4K
Granted 28.1K · Sold 11.6K
Granted 18.0K · Sold 935
Granted 48.7K · Sold 14.4K
Granted 16.0K
Granted 80.7K · Sold 52.5K
Granted 50.1K · Sold 39.5K
Granted 50.3K · Sold 32.2K
Granted 60.2K · Sold 22.5K
Granted 1.9K
Granted 14.4K · Bought 360 · Sold 45
Granted 148.7K · Sold 74.4K
Granted 13.0K
Granted 12.7K
Granted 20.2K · Sold 6.4K
Granted 32.6K · Sold 13.8K
Granted 80.3K · Sold 63.9K
Granted 81.7K · Sold 35.4K
Granted 42.6K · Sold 12.3K
Granted 7.3K · Bought 4.0K
Granted 10.9K · Sold 2.3K
Granted 9.6K
Granted 26.7K · Sold 4.2K
Granted 19.8K · Sold 11.0K
Granted 9.4K
Granted 39.1K · Sold 36.9K
Granted 7.1K · Bought 1.5K
Granted 9.2K · Sold 3.2K
Granted 2.7K
Granted 2.5K
Granted 23.4K · Sold 2.2K
Granted 21.2K · Sold 9.9K
Granted 1.9K · Bought 5.3K
Granted 4.3K · Bought 500
Granted 54.3K · Sold 19.4K
Granted 8.8K · Sold 4.4K
Granted 4.1K
Granted 4.8K
Granted 4.5K
Granted 2.1K
Granted 1.1K
Granted 3.3K
Granted 2.2K
Granted 18.0K · Sold 8.6K
Granted 5.2K · Sold 2.3K
Granted 7.5K · Sold 3.6K
Granted 17.6K · Sold 10.7K
Granted 475
Granted 1.3K
Granted 1.3K
Granted 3.1K · Sold 474
Granted 9.3K
Granted 5.5K · Sold 3.6K
Granted 14.3K
Granted 7.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Becton Henry P JrDirector · 153 transactions | — | 487.3Kas of Nov 2015 | 45.3K | — | 617.7K |
| Forlenza Vincent AChairman of the Board, Director · 156 transactions | — | 234.7Kas of Dec 2020 | 1.11M | — | 573.6K |
| Ludwig Edward JChairman, Director · 100 transactions | — | 163.1Kas of Jul 2012 | 1.28M | — | 1.16M |
| Kozy William AExecutive Vice President · 88 transactions | — | 125.2Kas of Dec 2015 | 608.5K | — | 452.3K |
| Polen Thomas E JrChairman, CEO and President, Director · 75 transactions | — | 108.2K | 307.2K | — | 53.0K |
| Considine John RVice Chairman · 20 transactions | — | 99.5Kas of Nov 2009 | 506.2K | — | 445.8K |
| Cohen Gary MExecutive Vice President · 111 transactions | — | 93.4Kas of Sep 2017 | 693.3K | — | 502.9K |
| Ring Timothy MDirector · 31 transactions | — | 61.4K | 495.3K | — | 311.8K |
| Hanson Alfred JohnExecutive Vice President · 21 transactions | — | 52.6Kas of Nov 2008 | 144.0K | — | 123.0K |
| Scott Bertram LDirector · 30 transactions | — | 36.8K | 35.6K | — | 8.1K |
| Conroy AlexandreEVP of Integrated Supply Chain · 59 transactions | — | 36.8Kas of Feb 2022 | 130.4K | — | 68.8K |
| Groetelaars John PEVP · 1 transaction | — | 36.4Kas of Jan 2018 | 6.2K | — | — |
| Larsen Marshall ODirector · 18 transactions | — | 28.9Kas of Jan 2023 | 22.5K | — | — |
| Reidy Christopher RCFO and EVP of Administration · 19 transactions | — | 28.6Kas of Nov 2021 | 58.1K | — | — |
| DelOrefice ChristopherEVP & Chief Financial Officer · 18 transactions | — | 27.2K | 36.0K | — | — |
| Lim James CExecutive Vice President · 57 transactions | — | 24.9Kas of Jun 2022 | 115.0K | — | 65.0K |
| Overlock Wilard J JrDirector · 28 transactions | — | 24.3Kas of Nov 2018 | 35.8K | 15.0K | 15.0K |
| Jones Christopher Ian MontagueDirector · 16 transactions | — | 24.3K | 19.4K | — | — |
| Orr James FDirector · 20 transactions | — | 24.3Kas of Jan 2017 | 31.9K | — | 13.0K |
| Anderson BasilDirector · 14 transactions | — | 24.1Kas of Jan 2017 | 22.4K | — | 2.2K |
| Neal Shana CarolEVP and Chief People Officer · 23 transactions | — | 24.0K | 31.9K | — | 2.6K |
| Perrella James EDirector · 2 transactions | — | 22.7Kas of Oct 2007 | 3.4K | — | — |
| Sherman Jeffrey SSr. VP and General Counsel · 68 transactions | — | 22.5Kas of May 2017 | 335.5K | — | 206.8K |
| Degraan EdwardDirector · 13 transactions | — | 22.4Kas of Jan 2015 | 22.3K | — | 4.4K |
| Fraser ClaireDirector · 20 transactions | — | 22.2K | 9.4K | — | 7.9K |
| Muhsin BilalEVP & President Connected Care · 2 transactions | — | 21.8K | 21.8K | — | — |
| Shrader Patricia BSenior Vice President · 19 transactions | — | 20.7Kas of Nov 2010 | 45.1K | — | 32.4K |
| Sommer AlfredDirector · 18 transactions | — | 20.7Kas of Jan 2014 | 28.1K | — | 11.6K |
| Feld MichaelEVP, Chief Revenue Officer · 18 transactions | — | 19.7K | 18.0K | — | 935 |
| Goette RolandEVP and President, EMEA · 49 transactions | — | 17.7K | 48.7K | — | 14.4K |
| Fraser-Liggett ClaireDirector · 9 transactions | — | 17.3Kas of Jan 2015 | 16.0K | — | — |
| Boles Donna MSenior VP - Human Resources · 35 transactions | — | 16.7Kas of May 2013 | 80.7K | — | 52.5K |
| Durack David TSenior Vice President · 63 transactions | — | 16.5Kas of Apr 2011 | 50.1K | — | 39.5K |
| Mas Ribo AlbertoEVP and Pres, Life Sciences · 32 transactions | — | 15.3Kas of Nov 2021 | 50.3K | — | 32.2K |
| Tharby Linda MExecutive Vice President · 31 transactions | — | 15.1Kas of Feb 2018 | 60.2K | — | 22.5K |
| Ugglas Margeretha AfDirector · 1 transaction | — | 14.4Kas of Feb 2007 | 1.9K | — | — |
| Burzik Catherine MDirector · 18 transactions | — | 14.3Kas of Jan 2025 | 14.4K | 360 | 45 |
| Sichak StephenExecutive Vice President · 60 transactions | — | 14.0Kas of Sep 2017 | 148.7K | — | 74.4K |
| Mahmoud AdelDirector · 7 transactions | — | 13.7Kas of Jan 2013 | 13.0K | — | — |
| Ezell Antoine CEVP, President Americas & CMO · 16 transactions | — | 13.3Kas of Nov 2024 | 12.7K | — | — |
| Byrd RichardEVP & President Interventional · 20 transactions | — | 13.2K | 20.2K | — | 6.4K |
| Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · 32 transactions | — | 13.2K | 32.6K | — | 13.8K |
| Tozzi William AEVP Pres Interventional · 38 transactions | — | 12.8Kas of Jul 2018 | 80.3K | — | 63.9K |
| Shabshab NabilExecutive Vice President · 39 transactions | — | 12.5Kas of May 2018 | 81.7K | — | 35.4K |
| Strahlman Ellen RSenior Vice President · 13 transactions | — | 11.7Kas of Nov 2017 | 42.6K | — | 12.3K |
| Minehan Cathy E.Director · 6 transactions | — | 11.5Kas of Feb 2011 | 7.3K | 4.0K | — |
| Rimel Rebecca WDirector · 15 transactions | — | 10.6Kas of Sep 2021 | 10.9K | — | 2.3K |
| Eckert R AndrewDirector · 11 transactions | — | 10.4K | 9.6K | — | — |
| Kaltenbach PatrickEVP & Pres Life Sciences · 23 transactions | — | 10.3Kas of Jul 2020 | 26.7K | — | 4.2K |
| Campion Simon DEVP and Segment President · 41 transactions | — | 10.3Kas of Feb 2022 | 19.8K | — | 11.0K |
| Pomeroy ClaireDirector · 9 transactions | — | 10.0Kas of Jan 2022 | 9.4K | — | — |
| Khichi Samrat S.EVP and General Counsel · 32 transactions | — | 9.3Kas of Dec 2022 | 39.1K | — | 36.9K |
| Henderson Jeffrey WilliamDirector · 9 transactions | — | 9.2K | 7.1K | 1.5K | — |
| Shan DavidEVP and Chief ISC Officer · 15 transactions | — | 8.9K | 9.2K | — | 3.2K |
| Roque VitorEVP & Chief Financial Officer · 2 transactions | — | 8.2K | 2.7K | — | — |
| Rhodes William E.Senior Vice President · 4 transactions | — | 7.3Kas of Nov 2012 | 2.5K | — | — |
| Mecklenburg Gary ADirector · 15 transactions | — | 7.3Kas of Nov 2018 | 23.4K | — | 2.2K |
| Borzi James WEVP & Chief Supply Chain Offcr · 24 transactions | — | 7.2Kas of Dec 2018 | 21.2K | — | 9.9K |
| Hayes GregoryDirector · 3 transactions | — | 7.2K | 1.9K | 5.3K | — |
| Melcher David FDirector · 7 transactions | — | 6.2Kas of Jan 2022 | 4.3K | 500 | — |
| Larson Betty DEVP HR & CHRO · 45 transactions | — | 5.9Kas of Feb 2022 | 54.3K | — | 19.4K |
| Hickey DavidEVP & President, Life Sciences · 10 transactions | — | 5.9Kas of Nov 2023 | 8.8K | — | 4.4K |
| Mocherla Pavan KumarEVP & President, Greater Asia · 9 transactions | — | 5.1K | 4.1K | — | — |
| Byington Carrie LDirector · 6 transactions | — | 5.0K | 4.8K | — | — |
| Brown William MDirector · 5 transactions | — | 4.7K | 4.5K | — | — |
| Quinn MichelleEVP and General Counsel · 4 transactions | — | 4.5Kas of Nov 2023 | 2.1K | — | — |
| Upadhyay SuketuSenior VP and Controller · 1 transaction | — | 3.6Kas of Nov 2012 | 1.1K | — | — |
| Waldstreicher JoanneDirector · 4 transactions | — | 3.4K | 3.3K | — | — |
| Spikner Pamela L.SVP Controller & CAO · 3 transactions | — | 3.3K | 2.2K | — | — |
| Hurwitz Jerome VExecutive Vice President · 19 transactions | — | 3.0Kas of May 2016 | 18.0K | — | 8.6K |
| Spoerel Thomas JSVPController & Chief Acct Off · 30 transactions | — | 2.2Kas of Jul 2024 | 5.2K | — | 2.3K |
| Bodner Charles RSVP Corp Fin Chief Acct Office · 10 transactions | — | 2.1Kas of Sep 2019 | 7.5K | — | 3.6K |
| Gallagher John EVP, Corp Finance and Treasurer · 23 transactions | — | 2.0Kas of Mar 2018 | 17.6K | — | 10.7K |
| Mercurio JosephVP and Corporate Controller · 2 transactions | — | 1.9Kas of Nov 2014 | 475 | — | — |
| Huffines Robert LutherDirector · 2 transactions | — | 1.3K | 1.3K | — | — |
| Wright JacquelineDirector · 2 transactions | — | 1.3K | 1.3K | — | — |
| Bruder Scott PSrVP, Chief Technology Officer · 4 transactions | — | 1.2Kas of Nov 2010 | 3.1K | — | 474 |
| Grover RishiEVP and Chief ISC Officer · 1 transaction | — | 99as of Jul 2022 | 9.3K | — | — |
| Elkins David VExecutive VP and CFO · 4 transactions | — | 0as of Nov 2012 | 5.5K | — | 3.6K |
| Menziuso PeterEVP and President, BDI · 1 transaction | — | 0 | 14.3K | — | — |
| Minnix LaneshaEVP and General Counsel · 1 transaction | — | 0 | 7.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -5.14M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.